CEO Doubles Down. $1.1M Against the Tape.
Leon Moulder just put $1.1 million of his own money into ZBIO at $17.79 while every technical indicator screams sell. This is his eighth buy in 12 months, and he's joined by two other insiders in the past 30 days. The short-term data backs aggressive CEO buying here — insiders on this name have been right two-thirds of the time at the 30-day mark. But the 90-day picture gets ugly fast, with most plays turning negative over longer holds.
The Filing
| Ticker | ZBIO |
| Company | Zenas BioPharma, Inc. |
| Insider | Leon Moulder Jr, Chief Executive Officer |
| Buy amount | $1.1M |
| Filing date | April 29, 2026 |
| Conviction | Favorable · 68/100 |
| Setup type | Contrarian Setup |
Ultimate members received this analysis in real time.